Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer

NCT05721300 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

2215

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Chronic Hepatitis B

Interventions

DRUG: NAs（"Entecavir"or"Tenofovir"or"Tenofovir alafenamide"） combined with interferon treatments
DRUG: NAs （"Entecavir"or"Tenofovir"or"Tenofovir alafenamide"） treatments

Sponsor

Zhongshan Hospital (Xiamen), Fudan University